Beyond 5‐year survival. A report from the Cooperative Osteosarcoma Study Group (COSS)

Documenti analoghi

• Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
  di: Stefan S. Bielack, et al.
  Pubblicazione: (2024)
• Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS )
  di: Stefan S. Bielack, et al.
  Pubblicazione: (2025)
• Prediction of 5‐year overall survival of diffuse large B‐cell lymphoma on the pola‐R‐CHP regimen based on 2‐year event‐free survival and progression‐free survival
  di: Wan‐Ru Zhang, et al.
  Pubblicazione: (2024)
• Pediatric Craniofacial Osteosarcoma: The Milano Experience
  di: Cristina Meazza, et al.
  Pubblicazione: (2025)
• Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
  di: Douglas J. Harrison, et al.
  Pubblicazione: (2024)